In this paper, we have focused on machine learning (ML) feature selection (FS) algorithms for identifying and diagnosing multidrug-resistant (MDR) tuberculosis (TB). MDR-TB is a universal public health problem, and its early detection has been one of the burning issues. The present study has been conducted in the Malakand Division of Khyber Pakhtunkhwa, Pakistan, to further add to the knowledge on the disease and to deal with the issues of identification and early detection of MDR-TB by ML algorithms. These models also identify the most important factors causing MDR-TB infection whose study gives additional insights into the matter.
ML algorithms such as random forest, k-nearest neighbors, support vector machine, logistic regression, leaset absolute shrinkage and selection operator (LASSO), artificial neural networks (ANNs), and decision trees are applied to analyse the case-control dataset. This study reveals that close contacts of MDR-TB patients, smoking, depression, previous TB history, improper treatment, and interruption in first-line TB treatment have a great impact on the status of MDR.
Accordingly, weight loss, chest pain, hemoptysis, and fatigue are important symptoms. Based on accuracy, sensitivity, and specificity, SVM and RF are the suggested models to be used for patients’ classifications.

Effect of the Inoculation Site of Bovine and Avian Purified Protein Derivatives (PPDs) on the Performance of the Intradermal Tuberculin Test in Goats From Tuberculosis-Free and Infected Herds
The single and comparative intradermal tuberculin (SIT and CIT) tests are used for the ante-mortem diagnosis of caprine tuberculosis (TB). The tuberculin injection site has been associated with a different performance of the test in cattle. In contrast to that required in cattle in Europe (cervical injection), it can be carried out in the scapular region in goats. Nevertheless, there are no previous data concerning the effect of the injection site on the performance of the test in goats.
The aim of the present study was to evaluate the effect of two different inoculation sites (cervical and scapular) on the performance of the SIT/CIT tests. This was done by intradermally inoculating 309 goats from two infected herds and one TB-free herd with both avian and bovine PPDs in the mid-cervical and scapular regions. None of the animals from the TB-free herd had positive reactions, and the number of reactors was not significantly higher, regardless of the inoculation site, in the high and low prevalence herds.
However, significantly higher increases in skin fold thickness were observed on the cervical site when compared to the scapular site after the avian and bovine PPD inoculations in the TB-free herd (p < 0.001) and after the bovine PPD injection in the high prevalence herd (p = 0.003).
The presence of clinical signs was also more evident on the cervical site when using avian and bovine PPDs in the high prevalence herd (p < 0.01). In contrast, increases in higher skin fold thickness were observed on the scapular site when compared to the cervical site after the bovine and avian PPD inoculations were employed in the low prevalence herd (p < 0.01).
These results suggest that the cervical injection of PPDs may improve the sensitivity of the intradermal tuberculin test in high TB prevalence caprine herds, mainly owing to the increased presence of local clinical signs and a better performance of the CIT test. Moreover, specificity was not affected when using standard interpretations, although further analyses in a great number of herds are required in order to confirm these findings.
Improved detection of Mycobacterium tuberculosis and M. bovis in African wildlife samples using cationic peptide decontamination and mycobacterial culture supplementation
In South Africa, mycobacterial culture is regarded as the gold standard for the detection of Mycobacterium tuberculosis complex (MTBC) infection in wildlife even though it is regarded as “imperfect.” We compared a novel decontamination and mycobacterial culture technique (TiKa) to the conventional mycobacterium growth indicator tube (MGIT) system using known amounts of bacilli and clinical samples from MTBC-infected African buffaloes (Syncerus caffer), white rhinoceros (Ceratotherium simum), and African elephants (Loxodonta africana).
Use of the TiKa-KiC decontamination agent on samples spiked with 10,000 to 10 colony forming units (cfu) of M. bovis (SB0121) and M. tuberculosis (H37Rv) had no effect on isolate recovery in culture. In contrast, decontamination with MGIT MycoPrep resulted in no growth of M. bovis samples at concentrations < 1,000 cfu and M. tuberculosis samples < 100 cfu.
Subsequently, we used the TiKa system with stored clinical samples (various lymphatic tissues) collected from wildlife and paucibacillary bronchoalveolar lavage fluid, trunk washes, and endotracheal tube washes from 3 species with known MTBC infections. Overall, MTBC recovery by culture was improved significantly (p < 0.01) by using TiKa compared to conventional MGIT, with 54 of 57 positive specimens versus 25 of 57 positive specimens, respectively.
The TiKa mycobacterial growth system appears to significantly enhance the recovery of MTBC members from tissue and paucibacillary respiratory samples collected from African buffaloes, African elephants, and white rhinoceros. Moreover, the TiKa system may improve success of MTBC culture from various sample types previously deemed unculturable from other species.
Engaging frontline providers: an important key to eliminating tuberculosis in Canada, and other high-income countries
The greatest human cost of the rapidly moving pandemic of SARS-CoV-2 may be due to its impact on the response to other diseases. One such other disease is tuberculosis (TB). All indications suggest that COVID-19-related diversions of healthcare resources and disruptions to public health programming will exacerbate the slower moving pandemic of TB. This is expected to set back TB elimination efforts by years. This is a prediction that is especially relevant to Canada, which has repeatedly failed to meet pre-set targets for the elimination of TB even before the COVID-19 pandemic began.
A collaborative approach to achieve TB elimination, one that engages all care providers, has recently been emphasized by the STOP-TB Partnership. Among TB elimination strategies, frontline providers (e.g., family physicians, emergency room physicians, and others) are well positioned to identify candidates for the treatment of latent TB infection, and make the diagnosis of infection-spreading cases of TB in a timely manner, thereby interrupting forward-moving chains of transmission.
Recombinant other ESAT6 Protein, His, Baculovirus-10ug |
QP11809-10ug |
EnQuireBio |
10ug |
EUR 241.2 |
Recombinant other ESAT6 Protein, His, Baculovirus-1mg |
QP11809-1mg |
EnQuireBio |
1mg |
EUR 6301.2 |
Recombinant other ESAT6 Protein, His, Baculovirus-2ug |
QP11809-2ug |
EnQuireBio |
2ug |
EUR 186 |
TB-M(Esat6+cfp10+tb16+tb38) |
E61H01305 |
EnoGene |
1mg |
EUR 957.6 |
Mycobacterium tuberculosis (M. tuberculosis) Antibody |
abx415707-1ml |
Abbexa |
1 ml |
EUR 727.2 |
|
CFP10 protein (Mycobacterium tuberculosis) |
30R-3240 |
Fitzgerald |
50 ug |
EUR 584.4 |
Description: Purified recombinant CFP10 protein (Mycobacterium tuberculosis) |
M. Tuberculosis HSP70 Protein |
abx060544-100ug |
Abbexa |
100 ug |
EUR 1378.8 |
|
M. tuberculosis CFP10, Protein |
abx061400-100ug |
Abbexa |
100 ug |
EUR 961.2 |
|
Mycobacterium Tuberculosis MoeX Protein |
20-abx260302 |
Abbexa |
-
EUR 1062.00
-
EUR 410.40
-
EUR 1930.80
|
|
|
M. Tuberculosis 38 kDa Protein |
abx060636-100ug |
Abbexa |
100 ug |
EUR 978 |
|
Myobacterium Tuberculosis DnaK (HSP70) Protein |
20-abx263478 |
Abbexa |
-
EUR 2047.20
-
EUR 393.60
-
EUR 276.00
|
|
|
Zmp1 M. tuberculosis Recombinant Protein |
90-361 |
ProSci |
50 ug |
EUR 752.1 |
Description: M13 endopeptidases are single-pass, transmembrane zinc-metallopeptidases responsible in human for the regulation of the biological activity of many hormones and peptides and are involved in many important processes such as blood pressure regulation (Neprilysin or NEP1), cardiovascular development (Endothelin Converting Enzyme-1 or ECE-12), prevention of haemolytic reaction (KELL) and phosphate homeostasis (PHEX). Zmp1 is a soluble enzyme member of the M13 endopeptidases family that plays a key role in Mycobacterium tuberculosis pathogenicity with a still unknown mechanism. Recently, it was shown to suppress inflammasome activation by inhibiting caspase-1 activation, thus preventing processing of pro-IL-1beta into IL-1beta and the consequent phagosome maturation. |
Recombinant Mycobacterium Tuberculosis CFP10 Protein |
VAng-Yyj0026-100g |
Creative Biolabs |
100 µg |
EUR 1309.2 |
Description: Mycobacterium Tuberculosis CFP10, recombinant protein. |
Recombinant Mycobacterium Tuberculosis CFP10 Protein |
VAng-Yyj0026-1mg |
Creative Biolabs |
1 mg |
EUR 3092.4 |
Description: Mycobacterium Tuberculosis CFP10, recombinant protein. |
Recombinant Mycobacterium Tuberculosis CFP10 Protein |
VAng-Yyj0026-500g |
Creative Biolabs |
500 µg |
EUR 2200.8 |
Description: Mycobacterium Tuberculosis CFP10, recombinant protein. |
Recombinant Mycobacterium Tuberculosis clpB Protein |
VAng-Yyj0029-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Chaperone protein ClpB (clpB), recombinant protein. |
Recombinant Mycobacterium Tuberculosis dnaG Protein |
VAng-Yyj0038-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis DNA primase (dnaG), recombinant protein. |
Recombinant Mycobacterium Tuberculosis dnaK Protein |
VAng-Yyj0039-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Chaperone protein DnaK (dnaK), recombinant protein. |
Recombinant Mycobacterium Tuberculosis fbiC Protein |
VAng-Yyj0045-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis FO synthase (fbiC), recombinant protein. |
Recombinant Mycobacterium Tuberculosis HSP Protein |
VAng-Yyj0063-10g |
Creative Biolabs |
10 µg |
EUR 2250 |
Description: Mycobacterium Tuberculosis, HSP, recombinant protein. |
Recombinant Mycobacterium Tuberculosis htpG Protein |
VAng-Yyj0064-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Chaperone protein htpG (htpG), recombinant protein. |
Recombinant Mycobacterium Tuberculosis malQ Protein |
VAng-Yyj0086-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis 4-alpha-glucanotransferase (malQ), recombinant protein. |
Recombinant Mycobacterium Tuberculosis MbtB Protein |
VAng-Yyj0092-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 4924.8 |
Description: Mycobacterium Tuberculosis Phenyloxazoline synthase MbtB (mbtB), recombinant protein. |
Recombinant Mycobacterium Tuberculosis MbtB Protein |
VAng-Yyj0092-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 3303.6 |
Description: Mycobacterium Tuberculosis Phenyloxazoline synthase MbtB (mbtB), recombinant protein. |
Recombinant Mycobacterium Tuberculosis mmpL10 Protein |
VAng-Yyj0097-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 4594.8 |
Description: Mycobacterium Tuberculosis Putative membrane protein mmpL10 (mmpL10), recombinant protein. |
Recombinant Mycobacterium Tuberculosis MoeX Protein |
VAng-Yyj0100-100g |
Creative Biolabs |
100 µg |
EUR 804 |
Description: Mycobacterium Tuberculosis MoeX, recombinant protein. |
Recombinant Mycobacterium Tuberculosis MoeX Protein |
VAng-Yyj0100-1mg |
Creative Biolabs |
1 mg |
EUR 3781.2 |
Description: Mycobacterium Tuberculosis MoeX, recombinant protein. |
Recombinant Mycobacterium Tuberculosis MoeX Protein |
VAng-Yyj0100-500g |
Creative Biolabs |
500 µg |
EUR 2187.6 |
Description: Mycobacterium Tuberculosis MoeX, recombinant protein. |
Recombinant Mycobacterium Tuberculosis mpa Protein |
VAng-Yyj0101-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Proteasome-associated ATPase (mpa), recombinant protein. |
Recombinant Mycobacterium Tuberculosis plsB1 Protein |
VAng-Yyj0125-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Putative acyltransferase plsB1 (plsB1), recombinant protein. |
Recombinant Mycobacterium Tuberculosis ppe11 Protein |
VAng-Yyj0128-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Uncharacterized PPE family protein PPE11 (ppe11), recombinant protein. |
Recombinant Mycobacterium Tuberculosis ppe12 Protein |
VAng-Yyj0129-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Uncharacterized PPE family protein PPE12 (ppe12), recombinant protein. |
Recombinant Mycobacterium Tuberculosis ppe16 Protein |
VAng-Yyj0130-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Uncharacterized PPE family protein PPE16 (ppe16), recombinant protein. |
Recombinant Mycobacterium Tuberculosis PPE2 Protein |
VAng-Yyj0132-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 4567.2 |
Description: Mycobacterium Tuberculosis Uncharacterized PPE family protein PPE2 (ppe2), recombinant protein. |
Recombinant Mycobacterium Tuberculosis PPE2 Protein |
VAng-Yyj0132-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 3064.8 |
Description: Mycobacterium Tuberculosis Uncharacterized PPE family protein PPE2 (ppe2), recombinant protein. |
Recombinant Mycobacterium Tuberculosis ppe28 Protein |
VAng-Yyj0134-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Uncharacterized PPE family protein PPE28 (ppe28), recombinant protein. |
Recombinant Mycobacterium Tuberculosis ppe40 Protein |
VAng-Yyj0138-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Uncharacterized PPE family protein PPE40 (ppe40), recombinant protein. |
Recombinant Mycobacterium Tuberculosis ppe42 Protein |
VAng-Yyj0139-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Uncharacterized PPE family protein PPE42 (ppe42), recombinant protein. |
Recombinant Mycobacterium Tuberculosis Rv1355c Protein |
VAng-Yyj0218-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Uncharacterized protein Rv1355c/MT1398 (Rv1355c, MT1398), recombinant protein. |
Recombinant Mycobacterium Tuberculosis Rv2100 Protein |
VAng-Yyj0251-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Uncharacterized protein Rv2100/MT2160 (Rv2100, MT2160), recombinant protein. |
Recombinant Mycobacterium Tuberculosis Rv2191 Protein |
VAng-Yyj0253-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Uncharacterized protein Rv2191/MT2247 (Rv2191, MT2247), recombinant protein. |
Recombinant Mycobacterium Tuberculosis Rv2900c Protein |
VAng-Yyj0295-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Uncharacterized protein Rv2900c/MT2968 (Rv2900c, MT2968), recombinant protein. |
Recombinant Mycobacterium Tuberculosis Rv2917 Protein |
VAng-Yyj0298-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Uncharacterized protein Rv2917/MT2985 (Rv2917, MT2985), recombinant protein. |
Recombinant Mycobacterium Tuberculosis tkt Protein |
VAng-Yyj0321-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Transketolase (tkt), recombinant protein. |
Recombinant Mycobacterium Tuberculosis ureC Protein |
VAng-Yyj0325-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Urease subunit alpha (ureC), recombinant protein. |
Recombinant Mycobacterium Tuberculosis Rv1343c Protein |
VAng-Yyj0662-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Mycobacterium Tuberculosis Uncharacterized protein Rv1343c/MT1384 (Rv1343c, MT1384), recombinant protein. |
Mycobacterium tuberculosis antibody |
20-MR50 |
Fitzgerald |
1 mg |
EUR 139.2 |
Description: Rabbit polyclonal Mycobacterium tuberculosis antibody |
Tuberculosis CFP10 antibody |
10-7852 |
Fitzgerald |
1 mg |
EUR 603.6 |
Description: Mouse monoclonal Tuberculosis CFP10 antibody |
Tuberculosis CFP10 antibody |
10-7853 |
Fitzgerald |
1 mg |
EUR 603.6 |
Description: Mouse monoclonal Tuberculosis CFP10 antibody |
Mycobacterium tuberculosis Antibody |
abx022066-1mg |
Abbexa |
1 mg |
EUR 1220.4 |
|
Mycobacterium tuberculosis Antibody |
abx022067-1mg |
Abbexa |
1 mg |
EUR 1296 |
|
Mycobacterium tuberculosis Antibody |
abx022073-1mg |
Abbexa |
1 mg |
EUR 1296 |
|
Mycobacterium tuberculosis Antibody |
abx022087-1mg |
Abbexa |
1 mg |
EUR 994.8 |
|
Mycobacterium tuberculosis Antibody |
abx022088-1mg |
Abbexa |
1 mg |
EUR 994.8 |
|
Mycobacterium tuberculosis Antibody |
abx022089-1mg |
Abbexa |
1 mg |
EUR 944.4 |
|
Mycobacterium tuberculosis Antibody |
abx022090-1mg |
Abbexa |
1 mg |
EUR 944.4 |
|
Mycobacterium tuberculosis Antibody |
abx023092-1ml |
Abbexa |
1 ml |
EUR 718.8 |
|
Mycobacterium tuberculosis Enoyl-[acyl-carrier-protein] reductase [NADH] (M. tuberculosis inhA) Antibody |
20-abx109426 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Mycobacterium tuberculosis Immunogenic protein MPT63 (mpt63) |
1-CSB-RP149074Ba(A3) |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mycobacterium tuberculosis Immunogenic protein MPT63(mpt63) expressed in E.coli |
Mycobacterium tuberculosis Immunogenic protein MPT64 (mpt64) |
1-CSB-YP358713MVZ |
Cusabio |
-
EUR 814.80
-
EUR 402.00
-
EUR 2606.40
-
EUR 1261.20
-
EUR 1730.40
-
EUR 522.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mycobacterium tuberculosis Immunogenic protein MPT64(mpt64) expressed in Yeast |
Mycobacterium tuberculosis Immunogenic protein MPT64 (mpt64) |
1-CSB-BP358713MVZ |
Cusabio |
-
EUR 1008.00
-
EUR 398.40
-
EUR 2604.00
-
EUR 1362.00
-
EUR 1894.80
-
EUR 564.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mycobacterium tuberculosis Immunogenic protein MPT64(mpt64) expressed in Baculovirus |
Mycobacterium tuberculosis Immunogenic protein MPT64 (mpt64) |
1-CSB-BP358713MVZb0 |
Cusabio |
-
EUR 1008.00
-
EUR 398.40
-
EUR 2604.00
-
EUR 1362.00
-
EUR 1894.80
-
EUR 564.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mycobacterium tuberculosis Immunogenic protein MPT64(mpt64) expressed in Baculovirus |
Mycobacterium tuberculosis Immunogenic protein MPT64 (mpt64) |
1-CSB-EP358713MVZ |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mycobacterium tuberculosis Immunogenic protein MPT64(mpt64) expressed in E.coli |
Mycobacterium tuberculosis Recombination protein RecR (recR) |
1-CSB-EP402913MON |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mycobacterium tuberculosis Recombination protein RecR(recR) expressed in E.coli |
Mycobacterium tuberculosis 38 kDa Recombinant Protein |
53-348 |
ProSci |
0.01 mg |
EUR 651.3 |
Description: Mycobacterium tuberculosis 38 kDa Recombinant Protein |
Mycobacterium tuberculosis HSP 70 Recombinant Protein |
53-349 |
ProSci |
0.01 mg |
EUR 789.9 |
Description: Mycobacterium tuberculosis HSP 70 Recombinant Protein |
Ketol-acid reductoisomerase Mycobacterium tuberculosis Protein |
20-abx169005 |
Abbexa |
-
EUR 1095.60
-
EUR 4468.80
-
EUR 393.60
|
|
|
NAD Kinase M. tuberculosis Recombinant Protein |
90-365 |
ProSci |
50 ug |
EUR 651.3 |
Description: NAD kinase catalyzes the transfer of a phosphate group from ATP to NAD+ to generate NADP+, which in its reduced form acts as an electron donor for biosynthetic reactions. NADP+ is an essential coenzyme in metabolism and provides reducing power to biosynthetic processes such as fatty acid biosynthesis. NAD kinase from Mycobacterium tuberculosis is not ATP-dependent but has a broader substrate specificity than human NAD kinase. It can economically produce NADP+ by using other nucleoside triphosphates as well as inorganic polyphosphate as a source of phosphorus. Was identified as a high-confidence drug target. Catalytic activity: ATP + NAD+ = ADP + NADP+ |
NAD Synthetase M. tuberculosis Recombinant Protein |
90-366 |
ProSci |
50 ug |
EUR 752.1 |
Description: NAD synthetase is an essential enzyme involved in both the de novo biosynthesis and salvage of NAD+, catalyzing the final step of both pathways. Since NAD has a vital role in cell metabolism, the enzyme represents a valid target for the development of new antimycobacterial agents. It can use both glutamine or ammonia as a nitrogen source. Catalytic activity: ATP + deamido-NAD+ + L-glutamine + H2O = AMP + diphosphate + NAD+ + L-glutamate |
DnaK (HSP70) Mycobacterium Tuberculosis Recombinant Protein |
PROTP19993 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: Recombinant Mycobacterium Tuberculosis Dnak produced in E.Coli is a single, non-glycosylated polypeptide chain containing 625 amino acids and having a molecular mass of 66.7 kDa. |
Recombinant Mycobacterium Tuberculosis Protein (38 kDa) |
VAng-Yyj0144-100g |
Creative Biolabs |
100 µg |
EUR 1225.2 |
Description: Mycobacterium Tuberculosis, recombinant protein (38 kDa). |
Ser / Thr protein kinase (Mycobacterium tuberculosis) Protein |
20-abx169014 |
Abbexa |
-
EUR 393.60
-
EUR 8043.60
-
EUR 1095.60
|
|
|
Myobacterium Tuberculosis Heat Shock Protein 65 Protein |
20-abx263477 |
Abbexa |
-
EUR 2047.20
-
EUR 393.60
-
EUR 276.00
|
|
|
Mycobacterium tuberculosis Enoyl-[acyl-carrier-protein] reductase [NADH] (M. tuberculosis inhA) Antibody (HRP) |
20-abx109170 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Mycobacterium tuberculosis Enoyl-[acyl-carrier-protein] reductase [NADH] (M. tuberculosis inhA) Antibody (Biotin) |
20-abx106339 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Mycobacterium tuberculosis Enoyl-[acyl-carrier-protein] reductase [NADH] (M. tuberculosis inhA) Antibody (FITC) |
20-abx107752 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Mycobacterium tuberculosis 16 kDa Antigen (M. tuberculosis 16 kDa) Antibody |
abx415759-01mg |
Abbexa |
0.1 mg |
EUR 760.8 |
|
Mycobacterium tuberculosis 38 kDa Antigen (M. tuberculosis 38 kDa) Antibody |
abx411025-02mg |
Abbexa |
0.2 mg |
EUR 678 |
|
Tuberculosis IgG ELISA Kit |
DEIA1023 |
Creative Diagnostics |
96T |
EUR 654 |
Description: This kit is an enzyme-linked immunosorbent assay for qualitative detection of IgG antibodies to Mycobacterium tuberculosis in human serum or plasma. It is intended for diagnosing and monitoring of patients related to infection by M. tuberculosis and other Mycobacteria. |
Tuberculosis IgG ELISA kit |
55R-IB79284 |
Fitzgerald |
96 wells |
EUR 382.8 |
Description: ELISA kit for the detection of Tuberculosis IgG in the research laboratory |
Tuberculosis IgM ELISA kit |
55R-IB79285 |
Fitzgerald |
96 wells |
EUR 382.8 |
Description: ELISA kit for the detection of Tuberculosis IgM in the research laboratory |
Mycobacterium tuberculosis RV2623 antibody |
10R-M139a |
Fitzgerald |
1 mg |
EUR 736.8 |
Description: Mouse monoclonal Mycobacterium tuberculosis RV2623 antibody |
Aspartate transaminase Mycobacterium tuberculosis |
20-abx072004 |
Abbexa |
-
EUR 1095.60
-
EUR 4302.00
-
EUR 393.60
|
|
|
Mycobacterium tuberculosis CFP10 Antibody |
abx022068-1mg |
Abbexa |
1 mg |
EUR 1111.2 |
|
Mycobacterium tuberculosis CFP10 Antibody |
abx022069-1mg |
Abbexa |
1 mg |
EUR 1111.2 |
|
Mycobacterium tuberculosis CFP10 Antibody |
abx022070-1mg |
Abbexa |
1 mg |
EUR 1111.2 |
|
Mycobacterium tuberculosis Hsp65 Antibody |
abx022091-1mg |
Abbexa |
1 mg |
EUR 1296 |
|
Mycobacterium tuberculosis Antibody (FITC) |
abx023089-1ml |
Abbexa |
1 ml |
EUR 718.8 |
|
Mycobacterium tuberculosis Antibody (Biotin) |
abx023090-1ml |
Abbexa |
1 ml |
EUR 718.8 |
|
Mycobacterium tuberculosis Antibody (HRP) |
abx023091-1ml |
Abbexa |
1 ml |
EUR 777.6 |
|
Mycobacterium tuberculosis PCR kit |
PCR-VH201-48D |
Bioingentech |
50T |
EUR 543.6 |
Mycobacterium tuberculosis PCR kit |
PCR-VH201-96D |
Bioingentech |
100T |
EUR 686.4 |
Mycobacterium Tuberculosis major secretory protein Antigen 85A Protein |
20-abx262511 |
Abbexa |
-
EUR 393.60
-
EUR 7676.40
-
EUR 276.00
|
|
|
Mycobacterium Tuberculosis major secretory protein Antigen 85B Protein |
20-abx263160 |
Abbexa |
-
EUR 1646.40
-
EUR 393.60
-
EUR 276.00
|
|
|
Mycobacterium tuberculosis PeptiDoglycan-binding protein ArfA (arfA) |
1-CSB-YP353360MVZ |
Cusabio |
-
EUR 814.80
-
EUR 402.00
-
EUR 2606.40
-
EUR 1261.20
-
EUR 1730.40
-
EUR 522.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mycobacterium tuberculosis PeptiDoglycan-binding protein ArfA(arfA) expressed in Yeast |
Recombinant Heat Shock Protein-70, Mycobacterium Tuberculosis |
DAG560 |
Creative Diagnostics |
100ug |
EUR 1194 |
Mycobacterium tuberculosis Hypoxic response protein 1 (hrp1) |
1-CSB-EP516950MVZ |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mycobacterium tuberculosis Hypoxic response protein 1(hrp1) expressed in E.coli |
Recombinant Myobacterium Tuberculosis Heat Shock Protein 65 |
7-07048 |
CHI Scientific |
2µg |
Ask for price |
Recombinant Myobacterium Tuberculosis Heat Shock Protein 65 |
7-07049 |
CHI Scientific |
10µg |
Ask for price |
Recombinant Myobacterium Tuberculosis Heat Shock Protein 65 |
7-07050 |
CHI Scientific |
100µg |
Ask for price |
Recombinant Mycobacterium Tuberculosis Antigen 85-A Protein |
VAng-Yyj0012-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 5493.6 |
Description: Mycobacterium Tuberculosis Antigen 85-A, recombinant protein. |
Recombinant Mycobacterium Tuberculosis Antigen 85-A Protein |
VAng-Yyj0012-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 3710.4 |
Description: Mycobacterium Tuberculosis Antigen 85-A, recombinant protein. |
Recombinant Mycobacterium Tuberculosis Antigen 85-A Protein |
VAng-Yyj0012-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 2530.8 |
Description: Mycobacterium Tuberculosis Antigen 85-A, recombinant protein. |
Recombinant Mycobacterium Tuberculosis Rv1367c Protein (aa 377) |
VAng-Yyj0220-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 2671.2 |
Description: Mycobacterium Tuberculosis Uncharacterized protein Rv1367c/MT1414 (Rv1367c, MT1414), recombinant protein. |
Mycobacterium tuberculosis Thymidylate kinase (tmk) |
1-CSB-EP007226MVZ |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mycobacterium tuberculosis Thymidylate kinase(tmk) expressed in E.coli |
Mycobacterium tuberculosis Antitoxin MT2731 (MT2731) |
1-CSB-YP300323MVZ |
Cusabio |
-
EUR 814.80
-
EUR 402.00
-
EUR 2606.40
-
EUR 1261.20
-
EUR 1730.40
-
EUR 522.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mycobacterium tuberculosis Antitoxin MT2731(MT2731) expressed in Yeast |
Mycobacterium tuberculosis IgG ELISA Kit |
DEIA381 |
Creative Diagnostics |
96T |
EUR 674.4 |
Description: The Mycobacterium tuberculosis IgG antibody ELISA kit has been designed for the detection andthe quantitative determination of specific IgG antibodies against Mycobacterium tuberculosis in serum and plasma. |
Mycobacterium tuberculosis IgA ELISA Kit |
DEIA382 |
Creative Diagnostics |
96T |
EUR 696 |
Description: The Mycobacterium tuberculosis IgA antibody ELISA kit has been designed for the detection andthe quantitative determination of specific IgA antibodies against Mycobacterium tuberculosis in serum and plasma. |
Mycobacterium tuberculosis IgM ELISA Kit |
DEIA383 |
Creative Diagnostics |
96T |
EUR 696 |
Description: The Mycobacterium tuberculosis IgM antibody ELISA kit has been designed for the detection andthe quantitative determination of specific IgM antibodies against Mycobacterium tuberculosis in serum and plasma. |
Mycobacterium tuberculosis Adenylate kinase (adk) |
1-CSB-EP404243MON |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mycobacterium tuberculosis Adenylate kinase(adk) expressed in E.coli |
Mycobacterium tuberculosis Mycothione reductase (mtr) |
1-CSB-EP517031MVZ |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mycobacterium tuberculosis Mycothione reductase(mtr) expressed in E.coli |
Mycobacterium tuberculosis Toxin RelG (relG) |
1-CSB-EP521896MVZ |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mycobacterium tuberculosis Toxin RelG(relG) expressed in E.coli |
Recombinant Myobacterium Tuberculosis DnaK (HSP70) |
7-06958 |
CHI Scientific |
2µg |
Ask for price |
Recombinant Myobacterium Tuberculosis DnaK (HSP70) |
7-06959 |
CHI Scientific |
10µg |
Ask for price |
Recombinant Myobacterium Tuberculosis DnaK (HSP70) |
7-06960 |
CHI Scientific |
100µg |
Ask for price |
Anti-Acr1 (M. tuberculosis) Purified |
11-185-C100 |
ExBio |
0.1 mg |
EUR 244.8 |
Anti-Tb10.4 (M. tuberculosis) Purified |
11-186-C100 |
ExBio |
0.1 mg |
EUR 244.8 |
Anti-Tb10.3 (M. tuberculosis) Purified |
11-187-C100 |
ExBio |
0.1 mg |
EUR 244.8 |
Anti-Acr2 (M. tuberculosis) Purified |
11-188-C100 |
ExBio |
0.1 mg |
EUR 244.8 |
Anti-Ag85b (M. tuberculosis) Purified |
11-189-C100 |
ExBio |
0.1 mg |
EUR 244.8 |
Anti-Tb7.7 (M. tuberculosis) Purified |
11-190-C100 |
ExBio |
0.1 mg |
EUR 244.8 |
Anti-GlcB (M. tuberculosis) Purified |
11-192-C100 |
ExBio |
0.1 mg |
EUR 244.8 |
Imidazoleglycerol-phosphate dehydratase Mycobacterium tuberculosis |
20-abx072006 |
Abbexa |
-
EUR 3232.80
-
EUR 1095.60
-
EUR 393.60
|
|
|
Mycobacterium tuberculosis antigen GlcB Antibody |
abx140170-01mg |
Abbexa |
0.1 mg |
EUR 510 |
|
Mycobacterium tuberculosis antigen Acr2 Antibody |
abx140171-01mg |
Abbexa |
0.1 mg |
EUR 510 |
|
Mycobacterium tuberculosis antigen Acr1 Antibody |
abx140172-01mg |
Abbexa |
0.1 mg |
EUR 510 |
|
Mycobacterium tuberculosis antigen Tb7.7 Antibody |
abx140173-01mg |
Abbexa |
0.1 mg |
EUR 510 |
|
Mycobacterium tuberculosis antigen Tb10.3 Antibody |
abx140174-01mg |
Abbexa |
0.1 mg |
EUR 510 |
|
Human Tuberculosis (TB) ELISA Kit |
abx055763-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Mycobacterium tuberculosis RT PCR kit |
RTq-VH201-100D |
Bioingentech |
100T |
EUR 860.4 |
Mycobacterium tuberculosis RT PCR kit |
RTq-VH201-150D |
Bioingentech |
150T |
EUR 969.6 |
Mycobacterium tuberculosis RT PCR kit |
RTq-VH201-50D |
Bioingentech |
50T |
EUR 717.6 |
Inactivated Mycobacterium Tuberculosis Chimeric Antigen |
VAng-Yyj0001-1mg |
Creative Biolabs |
1 mg |
EUR 2053.2 |
Description: Mycobacterium Tuberculosis Chimeric Antigen, native protein. |
Human Mycobacterium tuberculosis Immunogenic protein MPT64 ELISA kit |
E01M0361-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Human Mycobacterium tuberculosis Immunogenic protein MPT64 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Mycobacterium tuberculosis Immunogenic protein MPT64 ELISA kit |
E01M0361-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Human Mycobacterium tuberculosis Immunogenic protein MPT64 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Electronic medical records offer the promise of automating these processes. In this commentary, we promote broader engagement of the workforce across multiple sectors of medicine to reduce TB associated morbidity and mortality, interrupt transmission, and shrink the reservoir of latent TB infection.